Invention Grant
- Patent Title: Long lasting drug formulations
-
Application No.: US13346761Application Date: 2012-01-10
-
Publication No.: US08454948B2Publication Date: 2013-06-04
- Inventor: Andrew L. Pearlman , Baruch S. Stern
- Applicant: Andrew L. Pearlman , Baruch S. Stern
- Applicant Address: IL Misgav
- Assignee: Medgenics Medical Israel Ltd.
- Current Assignee: Medgenics Medical Israel Ltd.
- Current Assignee Address: IL Misgav
- Agency: Pearl Cohen Zedek Latzer, LLP
- Agent Mark S. Cohen
- Main IPC: A01N63/00
- IPC: A01N63/00
Abstract:
The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin.
Public/Granted literature
- US20120201784A1 LONG LASTING DRUG FORMULATIONS Public/Granted day:2012-08-09
Information query
